Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.37	69.89	70.87
Graham Fair Price	-74.88	9230.78	36748.36
PEG	50862.67	-0.75	< 0.005
Price/Book	-8.06	2.39	2.60
Price/Cash Flow	16.53	112.46	96.51
Prices/Earnings	1388.35	79.98	-5.37
Price/Sales	-24.58	11.86	15.73
Price/FCF	16.53	112.46	96.51
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.35	0.49	0.47
Operating Margin	-28.22	0.06	0.08
ROA	-93.87	< 0.005	-0.05
ROE	-0.12	< 0.005	-93.82
ROIC	0.01	< 0.005	-64.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.03	-8.74
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.03	-0.12	-273.20
EPS QOQ	-36.38	1.06	-97.08
FCF QOQ	-0.08	-0.20	-141.05
Revenue QOQ	-0.25	0.23	-8.26
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.64	11.79	-19.48
Days Sales Outstanding (DSO)	39.43	34.36	-12.86
Inventory Turnover	6.15	7.63	24.20
Debt/Capitalization	0.22	0.22	-1.56
Quick Ratio	1.06	1.19	12.11
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22281.11	22518.44	1.07
Cash	16691.22	16908.79	1.30
Capex	-532.82	-319.49	40.04
Free Cash Flow	599.94	478.39	-20.26
Revenue	3681.50	4535.51	23.20
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.22	1.36	11.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.92	-4.00	-36.83
Naive Interpretation	Member

06 - Financial Health · Weak

Rating